4//SEC Filing
French Glendon E. III 4
Accession 0001805624-25-000005
CIK 0001127537other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 7:51 PM ET
Size
11.9 KB
Accession
0001805624-25-000005
Insider Transaction Report
Form 4
Pulmonx CorpLUNG
French Glendon E. III
Director
Transactions
- Sale
Common Stock
2025-12-01$1.57/sh−2,524$3,963→ 283,605 total - Sale
Common Stock
2025-12-01$1.57/sh−6,281$9,861→ 277,324 total - Award
Common Stock
2025-12-01+1,200,000→ 1,477,324 total - Award
Performance Stock Units
2025-12-01+800,000→ 800,000 totalExp: 2028-12-01→ Common Stock (800,000 underlying)
Holdings
- 742,998(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2022.
- [F2]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
- [F3]Represents grant of RSUs payable solely in common stock of the Issuer that vests in equal quarterly installments over the three-year period following the date of grant of December 1, 2025.
- [F4]The shares are held by the Glendon E French & Gayle French Trustees French Family Rev Trust UA DTD 08/29/2012, of which the reporting person and his spouse are trustees and beneficiaries.
- [F5]Each Performance Stock Unit represents a contingent right to receive one share of the Issuer's common stock. The Performance Stock Units vest upon meeting the following two conditions: (a) upon the Issuer's common stock achieving a specified price per share and (b) with respect to 33% on the one year following the grant date of December 1, 2025 and the remainder in eight equal quarterly installments.
Documents
Issuer
Pulmonx Corp
CIK 0001127537
Entity typeother
Related Parties
1- filerCIK 0001805624
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 7:51 PM ET
- Size
- 11.9 KB